World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
45514
World Ranking
9125
National Ranking
4705

Overview

Paul A. Gurbel is affiliated with Inova Fairfax Hospital in the United States and has a substantial publication record in the field of medicine, with a strong focus on cardiology and cardiovascular medicine.

The scientist's research spans several subfields including:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Internal Medicine
  • Infectious Diseases
  • Epidemiology

Major topics covered in Paul A. Gurbel's work include:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 Clinical Research Studies
  • Lipoproteins and Cardiovascular Health

Frequent publication venues for Paul A. Gurbel's research are:

  • Journal of the American College of Cardiology
  • Circulation
  • Journal of Thrombosis and Thrombolysis
  • The American Journal of Cardiology
  • Thrombosis and Haemostasis

Some recent representative papers authored or co-authored by the researcher include:

  • The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease (2020), published in Thrombosis and Haemostasis
  • Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022), published in Nature Reviews Cardiology
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS (2020), published in European Heart Journal
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis (2021), published in European Heart Journal
  • Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome (2020), published in Circulation

Paul A. Gurbel frequently collaborates with several co-authors, including:

  • Udaya S. Tantry
  • Kevin P. Bliden
  • Sahib Singh
  • Young-Hoon Jeong
  • Rahul Chaudhary

Best Publications

  • Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

    Paul A. Gurbel;Kevin P. Bliden;Bonnie L. Hiatt;Christopher M. O’Connor

  • Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

    Alan R. Shuldiner;Jeffrey R. O’Connell;Kevin P. Bliden;Amish Gandhi

  • Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study

    Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Udaya S. Tantry

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

    Gregg W. Stone;Bernhard Witzenbichler;Giora Weisz;Michael J. Rinaldi

  • Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  • Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.

    Paul A. Gurbel;Kevin P. Bliden;Kirk Guyer;Peter W. Cho

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance

    Wei C. Lau;Paul A. Gurbel;Paul B. Watkins;Charlene J. Neer

  • Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.

    Paul A. Gurbel;Kevin P. Bliden;Waiel Samara;Jason A. Yoho

  • Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

    Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Mark J. Antonino

  • Platelet function monitoring in patients with coronary artery disease

    Paul A. Gurbel;Richard C. Becker;Kenneth G. Mann;Steven R. Steinhubl

  • Evaluation of Dose-Related Effects of Aspirin on Platelet Function Results From the Aspirin-Induced Platelet Effect (ASPECT) Study

    Paul A. Gurbel;Kevin P. Bliden;Joseph DiChiara;Justin Newcomer

  • Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate?

    Kevin P. Bliden;Joseph DiChiara;Udaya S. Tantry;Ashwani K. Bassi

  • Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

    Robert F. Storey;Steen Husted;Robert A. Harrington;Stanley Heptinstall

  • The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting

    Paul A. Gurbel;Kevin P. Bliden;Kevin M. Hayes;Jason A. Yoho

  • Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

    Eliano Pio Navarese;Michalina Kołodziejczak;Volker Schulze;Paul A. Gurbel

  • Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

    Dirk Sibbing;Daniel Aradi;Dimitrios Alexopoulos;Jurrien ten Berg

Frequent Co-Authors

Udaya S. Tantry
Udaya S. Tantry Johns Hopkins University
Dominick J. Angiolillo
Dominick J. Angiolillo University of Florida
E. Magnus Ohman
E. Magnus Ohman Duke University
Dean J. Kereiakes
Dean J. Kereiakes The Christ Hospital Health Network
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Robert F. Storey
Robert F. Storey University of Sheffield
Alan R. Shuldiner
Alan R. Shuldiner University of Maryland, Baltimore
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Matthew T. Roe
Matthew T. Roe Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond studying Medicine in the USA, many students explore alternative healthcare degrees online. These pathways can provide greater flexibility and may shorten the time to begin a rewarding medical career.

Advanced nursing roles are in high demand. Consider the online dnp programs for those aiming for leadership or educational positions in nursing. For those seeking a less rigorous entry, there are also options among the easiest online dnp programs.

If you want to join the healthcare workforce sooner, fast lpn program options allow you to become a Licensed Practical Nurse quickly. Additionally, for those interested in mental health, the shortest pmhnp program lets you become a Psychiatric Mental Health Nurse Practitioner in less time.

These online degrees and fast-track programs help open doors to diverse careers in healthcare, offering alternative routes to those interested in patient care, leadership, or specialty practice areas.

Best Scientists Citing Paul A. Gurbel

Trending Scientists